Oral Session 2-8A Transplant for acule leukemia

[OS2-8A-6] Circulating tumor DNA predicts relapse after allo-SCT in AML and MDS

Sousuke Nakamura¹, Kazuaki Yokoyama^1,2, Nozomi Yusa³, Kanya Kondoh¹, Miho Ogawa¹, Tomomi Takei¹, Asako Kobayashi¹, Mika Ito¹, Koji Jimbo^1,2, Susumu Tanoue², Masamichi Isobe², Takaaki Konuma², Seiko Kato², Eigo Shimizu⁴, Rika Kasajima⁵, Yuka Wada⁶, Rui Yamaguchi⁴, Seiya Imoto⁵, Tokiko Nagamura-Inoue⁶, Satoshi Takahashi¹, Satoru Miyano^4,5, Arinobu Tojo^1,2 (1.Division of Molecular Therapy, IMSUT, University of Tokyo, 2.Department of Hematology/Oncology, IMSUT Hospital, University of Tokyo, 3.Department of Applied Genomics, IMSUT Hospital, University of Tokyo, 4.Laboratory of DNA Information Analysis, IMSUT, University of Tokyo, 5.Health Intelligence Center, IMSUT, University of Tokyo, 6.Department of Cell Processing and Transfusion, IMSUT, University of Tokyo)